BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27291650)

  • 1. Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4.
    Zhang Q; Zeng L; Shen C; Ju Y; Konuma T; Zhao C; Vakoc CR; Zhou MM
    Structure; 2016 Jul; 24(7):1201-8. PubMed ID: 27291650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the Brd4 ET domain bound to a C-terminal motif from γ-retroviral integrases reveals a conserved mechanism of interaction.
    Crowe BL; Larue RC; Yuan C; Hess S; Kvaratskhelia M; Foster MP
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2086-91. PubMed ID: 26858406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Mechanism of the Oxygenase JMJD6 Recognition by the Extraterminal (ET) Domain of BRD4.
    Konuma T; Yu D; Zhao C; Ju Y; Sharma R; Ren C; Zhang Q; Zhou MM; Zeng L
    Sci Rep; 2017 Nov; 7(1):16272. PubMed ID: 29176719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.
    Shen C; Ipsaro JJ; Shi J; Milazzo JP; Wang E; Roe JS; Suzuki Y; Pappin DJ; Joshua-Tor L; Vakoc CR
    Mol Cell; 2015 Dec; 60(6):847-59. PubMed ID: 26626481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common binding motif in the ET domain of BRD3 forms polymorphic structural interfaces with host and viral proteins.
    Aiyer S; Swapna GVT; Ma LC; Liu G; Hao J; Chalmers G; Jacobs BC; Montelione GT; Roth MJ
    Structure; 2021 Aug; 29(8):886-898.e6. PubMed ID: 33592170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.
    Rahman S; Sowa ME; Ottinger M; Smith JA; Shi Y; Harper JW; Howley PM
    Mol Cell Biol; 2011 Jul; 31(13):2641-52. PubMed ID: 21555454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Murine Leukemia Virus Integrase-Derived Peptides That Bind Brd4 Extra-Terminal Domain as Candidates for Suppression of Acute Myeloid Leukemia.
    Xing E; Surendranathan N; Kong X; Cyberski N; Garcia JD; Cheng X; Sharma A; Li PK; Larue RC
    ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1628-1638. PubMed ID: 34661079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.
    Raj U; Kumar H; Varadwaj PK
    J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution.
    Vollmuth F; Blankenfeldt W; Geyer M
    J Biol Chem; 2009 Dec; 284(52):36547-36556. PubMed ID: 19828451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intrinsic kinase activity of BRD4 spans its BD2-B-BID domains.
    Weissman JD; Singh AK; Devaiah BN; Schuck P; LaRue RC; Singer DS
    J Biol Chem; 2021 Nov; 297(5):101326. PubMed ID: 34688663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Backbone resonance assignments for the SET domain of human methyltransferase NSD3 in complex with its cofactor.
    Li Y; Ng HQ; Ngo A; Liu S; Tan YW; Kwek PZ; Hung AW; Joy J; Hill J; Keller TH; Kang C
    Biomol NMR Assign; 2017 Oct; 11(2):225-229. PubMed ID: 28808922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors.
    Ember SW; Zhu JY; Olesen SH; Martin MP; Becker A; Berndt N; Georg GI; Schönbrunn E
    ACS Chem Biol; 2014 May; 9(5):1160-71. PubMed ID: 24568369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.
    Lin YJ; Umehara T; Inoue M; Saito K; Kigawa T; Jang MK; Ozato K; Yokoyama S; Padmanabhan B; Güntert P
    Protein Sci; 2008 Dec; 17(12):2174-9. PubMed ID: 18815416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of histone methyltransferase NSD3 on ISO-induced cardiac hypertrophy.
    Chen K; Jian D; Zhao L; Zang X; Song W; Ma J; Jia Z; Wang X; Gao C
    FEBS Lett; 2019 Sep; 593(18):2556-2565. PubMed ID: 31254363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1.
    Tumdam R; Kumar A; Subbarao N; Balaji BS
    SAR QSAR Environ Res; 2018 Dec; 29(12):975-996. PubMed ID: 30411639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.
    You J; Srinivasan V; Denis GV; Harrington WJ; Ballestas ME; Kaye KM; Howley PM
    J Virol; 2006 Sep; 80(18):8909-19. PubMed ID: 16940503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain.
    Lolli G; Battistutta R
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2161-4. PubMed ID: 24100334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.
    Morishita M; Mevius D; di Luccio E
    BMC Struct Biol; 2014 Dec; 14():25. PubMed ID: 25494638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into the regulation and the recognition of histone marks by the SET domain of NSD1.
    Morishita M; di Luccio E
    Biochem Biophys Res Commun; 2011 Aug; 412(2):214-9. PubMed ID: 21806967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding mechanism of NHWD-870 to bromodomain-containing protein 4 based on molecular dynamics simulations and free energy calculation.
    Shi M; He J; Weng T; Shi N; Qi W; Guo Y; Chen T; Chen L; Xu D
    Phys Chem Chem Phys; 2022 Feb; 24(8):5125-5137. PubMed ID: 35156677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.